Metraipolis › archive › dc_ef1f0ea2ae6a

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma — Europe PMC PMID:42129310

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42129310
DOI
10.1038/s41409-[numero omesso]-1
License (as archived)
solo-consultazione
Archived
2026-10-07T21:22:36.628Z
SHA-256 of the archived text
67940e0cc0bf7786db9182fa0630997d574dd17fa50230038ea29a4461e364e6
Stable URL of this page
https://metraipolis.com/documento/dc_ef1f0ea2ae6a

How to cite

Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma — Europe PMC PMID:42129310 — Europe PMC (en), https://europepmc.org/article/MED/42129310 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ef1f0ea2ae6a (Metraipolis archive dc_ef1f0ea2ae6a, sha256 67940e0cc0bf7786db9182fa0630997d574dd17fa50230038ea29a4461e364e6)
BibTeX
@misc{dcef1f0ea2ae6a,
  title = {Experiences and expert panel consensus on bridging therapy before anti-BCMA CAR-T cell therapy in multiple myeloma — Europe PMC PMID:42129310},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42129310},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ef1f0ea2ae6a; sha256 67940e0cc0bf7786db9182fa0630997d574dd17fa50230038ea29a4461e364e6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42129310. Agents can read the archived copy with the MCP tool read_document.